155 related articles for article (PubMed ID: 21303222)
1. Elastic liposomes as carriers for oral delivery and the brain distribution of (+)-catechin.
Huang YB; Tsai MJ; Wu PC; Tsai YH; Wu YH; Fang JY
J Drug Target; 2011 Sep; 19(8):709-18. PubMed ID: 21303222
[TBL] [Abstract][Full Text] [Related]
2. Engineered chylomicron mimicking carrier emulsome for lymph targeted oral delivery of methotrexate.
Paliwal R; Paliwal SR; Mishra N; Mehta A; Vyas SP
Int J Pharm; 2009 Oct; 380(1-2):181-8. PubMed ID: 19576973
[TBL] [Abstract][Full Text] [Related]
3. Oral peptide delivery by tetraether lipid liposomes.
Parmentier J; Thewes B; Gropp F; Fricker G
Int J Pharm; 2011 Aug; 415(1-2):150-7. PubMed ID: 21664955
[TBL] [Abstract][Full Text] [Related]
4. Baicalein loaded in tocol nanostructured lipid carriers (tocol NLCs) for enhanced stability and brain targeting.
Tsai MJ; Wu PC; Huang YB; Chang JS; Lin CL; Tsai YH; Fang JY
Int J Pharm; 2012 Feb; 423(2):461-70. PubMed ID: 22193056
[TBL] [Abstract][Full Text] [Related]
5. Alginate microspheres of isoniazid for oral sustained drug delivery.
Rastogi R; Sultana Y; Aqil M; Ali A; Kumar S; Chuttani K; Mishra AK
Int J Pharm; 2007 Apr; 334(1-2):71-7. PubMed ID: 17113732
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of alginate-chitosan microspheres for oral delivery of insulin.
Zhang Y; Wei W; Lv P; Wang L; Ma G
Eur J Pharm Biopharm; 2011 Jan; 77(1):11-9. PubMed ID: 20933083
[TBL] [Abstract][Full Text] [Related]
7. Novel O-palmitoylscleroglucan-coated liposomes as drug carriers: development, characterization and interaction with leuprolide.
Carafa M; Marianecci C; Annibaldi V; Di Stefano A; Sozio P; Santucci E
Int J Pharm; 2006 Nov; 325(1-2):155-62. PubMed ID: 16884870
[TBL] [Abstract][Full Text] [Related]
8. Tamoxifen in topical liposomes: development, characterization and in-vitro evaluation.
Bhatia A; Kumar R; Katare OP
J Pharm Pharm Sci; 2004 Jul; 7(2):252-9. PubMed ID: 15367383
[TBL] [Abstract][Full Text] [Related]
9. Hypoglycemic activity and oral bioavailability of insulin-loaded liposomes containing bile salts in rats: the effect of cholate type, particle size and administered dose.
Niu M; Lu Y; Hovgaard L; Guan P; Tan Y; Lian R; Qi J; Wu W
Eur J Pharm Biopharm; 2012 Jun; 81(2):265-72. PubMed ID: 22369880
[TBL] [Abstract][Full Text] [Related]
10. Integrity and stability of oral liposomes containing bile salts studied in simulated and ex vivo gastrointestinal media.
Hu S; Niu M; Hu F; Lu Y; Qi J; Yin Z; Wu W
Int J Pharm; 2013 Jan; 441(1-2):693-700. PubMed ID: 23089580
[TBL] [Abstract][Full Text] [Related]
11. Preparation and pH stability of ferrous glycinate liposomes.
Ding B; Xia S; Hayat K; Zhang X
J Agric Food Chem; 2009 Apr; 57(7):2938-44. PubMed ID: 19253959
[TBL] [Abstract][Full Text] [Related]
12. Preparation, characterization, and in vivo evaluation of intranasally administered liposomal formulation of donepezil.
Al Asmari AK; Ullah Z; Tariq M; Fatani A
Drug Des Devel Ther; 2016; 10():205-15. PubMed ID: 26834457
[TBL] [Abstract][Full Text] [Related]
13. Enhanced bioavailability of the poorly water-soluble drug fenofibrate by using liposomes containing a bile salt.
Chen Y; Lu Y; Chen J; Lai J; Sun J; Hu F; Wu W
Int J Pharm; 2009 Jul; 376(1-2):153-60. PubMed ID: 19394416
[TBL] [Abstract][Full Text] [Related]
14. Preparation, characterization and in vivo pharmacokinetic study of PVP-modified oleanolic acid liposomes.
Liu Y; Luo X; Xu X; Gao N; Liu X
Int J Pharm; 2017 Jan; 517(1-2):1-7. PubMed ID: 27899320
[TBL] [Abstract][Full Text] [Related]
15. Chitosomes as drug delivery systems for C-phycocyanin: preparation and characterization.
Manconi M; Mura S; Manca ML; Fadda AM; Dolz M; Hernandez MJ; Casanovas A; Díez-Sales O
Int J Pharm; 2010 Jun; 392(1-2):92-100. PubMed ID: 20338230
[TBL] [Abstract][Full Text] [Related]
16. Anti-inflammatory activity of gel containing novel elastic niosomes entrapped with diclofenac diethylammonium.
Manosroi A; Jantrawut P; Manosroi J
Int J Pharm; 2008 Aug; 360(1-2):156-63. PubMed ID: 18539416
[TBL] [Abstract][Full Text] [Related]
17. Chitosan nanoparticles encapsulated vesicular systems for oral immunization: preparation, in-vitro and in-vivo characterization.
Jain S; Sharma RK; Vyas SP
J Pharm Pharmacol; 2006 Mar; 58(3):303-10. PubMed ID: 16536896
[TBL] [Abstract][Full Text] [Related]
18. Development of vitamin loaded topical liposomal formulation using factorial design approach: drug deposition and stability.
Padamwar MN; Pokharkar VB
Int J Pharm; 2006 Aug; 320(1-2):37-44. PubMed ID: 16707237
[TBL] [Abstract][Full Text] [Related]
19. Improved oral bioavailability of breviscapine via a Pluronic P85-modified liposomal delivery system.
Zhou Y; Ning Q; Yu DN; Li WG; Deng J
J Pharm Pharmacol; 2014 Jul; 66(7):903-11. PubMed ID: 24697705
[TBL] [Abstract][Full Text] [Related]
20. Development and in-vivo evaluation of insulin-loaded chitosan phthalate microspheres for oral delivery.
Ubaidulla U; Khar RK; Ahmed FJ; Panda AK
J Pharm Pharmacol; 2007 Oct; 59(10):1345-51. PubMed ID: 17910808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
